Reporting on their study with lab-grown human cells, researchers at The Johns Hopkins University and the University of Maryland say that blocking a second blood vessel growth protein, along with one that ...
9 hours ago
Team identifies inflammatory pathway that offers VEGF-independent target for diabetic macular edema drugs
Diabetic macular edema (DME) is a leading source of vision loss around the world, affecting about a fifth of people with long-term diabetes. Drugs that target a protein known as VEGF (vascular endothelial ...
May 19, 2015